Targeted therapeutic options and future perspectives for HER2-positive breast cancer
J Wang, B Xu - Signal transduction and targeted therapy, 2019 - nature.com
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - Bioscience reports, 2015 - portlandpress.com
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
Drugs, their targets and the nature and number of drug targets
P Imming, C Sinning, A Meyer - Nature reviews Drug discovery, 2006 - nature.com
Drugs, their targets and the nature and number of drug targets | Nature Reviews Drug Discovery
Skip to main content Thank you for visiting nature.com. You are using a browser version with …
Skip to main content Thank you for visiting nature.com. You are using a browser version with …
Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
MC Ochoa, L Minute, I Rodriguez… - Immunology and cell …, 2017 - Wiley Online Library
Antibody‐dependent cellular cytotoxicity (ADCC) is a set of mechanisms that target cells
coated with IgG antibodies of the proper subclasses (IgG1 in the human) to be the prey of …
coated with IgG antibodies of the proper subclasses (IgG1 in the human) to be the prey of …
Design of liposomal formulations for cell targeting
E Nogueira, AC Gomes, A Preto… - Colloids and surfaces B …, 2015 - Elsevier
Liposomes have gained extensive attention as carriers for a wide range of drugs due to
being both nontoxic and biodegradable as they are composed of substances naturally …
being both nontoxic and biodegradable as they are composed of substances naturally …
Targeting multiple signal transduction pathways through inhibition of Hsp90
H Zhang, F Burrows - Journal of molecular medicine, 2004 - Springer
The multichaperone heat shock protein (Hsp) 90 complex mediates the maturation and
stability of a variety of proteins, many of which are crucial in oncogenesis, including …
stability of a variety of proteins, many of which are crucial in oncogenesis, including …
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric …
A Christopoulos, JP Changeux, WA Catterall… - Pharmacological …, 2014 - ASPET
Allosteric interactions play vital roles in metabolic processes and signal transduction and,
more recently, have become the focus of numerous pharmacological studies because of the …
more recently, have become the focus of numerous pharmacological studies because of the …
The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition
EL Ma, YJ Choi, J Choi, C Pothoulakis… - … journal of cancer, 2010 - Wiley Online Library
A wealth of data implicates that ErbB receptors have essential roles in tumor development.
Probiotic bacteria are known to exert an anticancer activity in animal studies. Bacillus …
Probiotic bacteria are known to exert an anticancer activity in animal studies. Bacillus …
A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects
SE Strome, EA Sausville, D Mann - The oncologist, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe the
relationship between antibody structure and effector function, and identify strategies for …
relationship between antibody structure and effector function, and identify strategies for …